Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cell Metabolism|May 8, 2008
The CAMplexities of central ghrelinMark W Sleeman, Esther Latres
Tissue Engineering. Part B, Reviews|September 10, 2020
3D Bioprinting and Translation of Beta Cell Replacement Therapies for Type 1 DiabetesRachel E Gurlin, Jaime A Giraldo, Esther Latres
Cell Metabolism|March 7, 2019
Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell TherapyEsther Latres, Daniel A Finan, Julia L Greenstein, et al.
Molecular and Cellular Biology|September 2, 2004
Role of F-box protein betaTrcp1 in mammary gland development and tumorigenesisYasusei Kudo, Daniele Guardavaccaro, Patricia G Santamaria, et al.
The Journal of Cell Biology|June 10, 2009
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylationShenhav Cohen, Jeffrey J Brault, Steven P Gygi, et al.
Proteomics|May 24, 2016
Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscleRobert R Salzler, Darshit Shah, Anthony Doré, et al.
Diabetes|February 17, 2007
Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasisHaruka Okamoto, Esther Latres, Rong Liu, et al.
The Journal of Biological Chemistry|November 20, 2004
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathwayEsther Latres, Ami R Amini, Ashley A Amini, et al.
Diabetes, Obesity & Metabolism|April 11, 2025
An open-label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerabilityEsther Latres, Leona Plum-Moerschel, Sundara Moorthi Nainar Murugesan, et al.
Diabetes|July 15, 2025
Future Directions and Clinical Trial Considerations for Novel Islet β-Cell Replacement Therapies for Type 1 DiabetesMarjana Marinac, Michael R Rickels, Jason L Gaglia, et al.
Pageof 3